Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Southeast Asian ovalocytosis (SAO) is a benign red cell membrane disorder caused by a 27-base-pair in-frame deletion in the SLC4A1 gene, which encodes the erythroid anion exchanger 1 (AE1 or band 3). Heterozygous carriers exhibit characteristic stomatocytic ovalocytes but maintain normal renal acidification and electrolyte balance (PMID:10352205). SAO is highly prevalent in Southeast Asian populations and has also been reported in non-Asian groups, including Amerindian-ancestry individuals in Mexico, indicating a possible founder effect or ancient migration (PMID:16392641).
SAO is inherited in an autosomal dominant manner. Multiple unrelated heterozygous individuals across at least five independent pedigrees have been identified, with no evidence of recessive or compound heterozygous inheritance for ovalocytosis alone (PMID:15115146). Segregation analysis in multiplex families confirms complete penetrance of the ovalocytic phenotype in heterozygotes without renal involvement. No additional affected relatives have been reported beyond heterozygous carriers.
The defining mutation is a 27-bp deletion spanning codons 400–408 (c.1199_1225del (p.Ser400_Gly408del)) in the AE1 membrane domain, corresponding to the “delta400-408” allele. This allele is recurrent in Southeast Asian populations and has been demonstrated in American and Mexican individuals with no Asian ancestry, suggesting a shared ancestral origin (PMID:15115146).
Functional studies in Xenopus oocytes show that the AE1 SAO polypeptide is correctly inserted into microsomal membranes and traffics to the cell surface comparably to wild-type AE1 but does not impair anion exchange activity or exert a dominant-negative effect on co-expressed wild-type AE1 (PMID:8606369). Likewise, human erythrocytes from SAO carriers retain normal chloride/bicarbonate exchange rates, indicating that the ovalocytic shape results from altered cytoskeletal interactions rather than transport deficiency.
Taken together, genetic and functional concordance across diverse cohorts establishes a definitive association between the SLC4A1 delta400-408 allele and SAO. The SAO variant serves as a clinically informative benign biomarker of red cell morphology with no major systemic implications.
Key Take-home: The SLC4A1 c.1199_1225del (p.Ser400_Gly408del) mutation causes autosomal dominant Southeast Asian ovalocytosis through an in-frame deletion that alters red cell shape without compromising anion exchange.
Gene–Disease AssociationDefinitiveSAO delta400-408 identified in multiple unrelated heterozygotes across diverse populations with complete penetrance Genetic EvidenceStrongDelta400-408 allele found in >100 heterozygous carriers in at least five independent pedigrees; founder effect supported Functional EvidenceModerateOocyte and erythrocyte assays show normal trafficking and retained transport function of AE1 SAO |